4
Changes in Ownership
Beam Therapeutics Inc. Filed Acc 0000899243-21-000430
CFO sold 25,000 shares at an average $81.78 ($2,044,485)
- CFO acquired 25,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Burrell Terry-Ann · CFO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 1 in the form | +25,000 | $13.68 | $342,000 | 32,309 | D |
| 2021-01-04 | Sale : show line 2 in the form | −800 | $78.05 | $62,440 | 31,509 | D |
| 2021-01-04 | Sale : show line 3 in the form | −1,951 | $79.21 | $154,539 | 29,558 | D |
| 2021-01-04 | Sale : show line 4 in the form | −2,449 | $80.25 | $196,532 | 27,109 | D |
| 2021-01-04 | Sale : show line 5 in the form | −6,509 | $81.26 | $528,921 | 20,600 | D |
| 2021-01-04 | Sale : show line 6 in the form | −5,296 | $82.44 | $436,602 | 15,304 | D |
| 2021-01-04 | Sale : show line 7 in the form | −7,095 | $83.15 | $589,949 | 8,209 | D |
| 2021-01-04 | Sale : show line 8 in the form | −900 | $83.89 | $75,501 | 7,309 | D |
| Open-market sales · 25,000 sh · avg $81.78 · $2,044,485 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-01-04 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −25,000 | 357,941 | D |
Loading xslF345X03/doc4.xml…